1. Home
  2. AUR vs PTGX Comparison

AUR vs PTGX Comparison

Compare AUR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Innovation Inc.

AUR

Aurora Innovation Inc.

HOLD

Current Price

$6.50

Market Cap

11.4B

Sector

Technology

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$148.09

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUR
PTGX
Founded
2017
2006
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.4B
9.3B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
AUR
PTGX
Price
$6.50
$148.09
Analyst Decision
Buy
Strong Buy
Analyst Count
4
13
Target Price
$9.43
$108.23
AVG Volume (30 Days)
29.4M
443.3K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
4.35
N/A
EPS
N/A
2.35
Revenue
$3,000,000.00
N/A
Revenue This Year
$407.30
$874.25
Revenue Next Year
$1,134.58
N/A
P/E Ratio
N/A
$61.74
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$57.90
52 Week High
$8.57
$160.81

Technical Indicators

Market Signals
Indicator
AUR
PTGX
Relative Strength Index (RSI) 52.75 46.83
Support Level $5.53 $141.95
Resistance Level $6.75 $160.81
Average True Range (ATR) 0.31 5.60
MACD 0.07 -1.45
Stochastic Oscillator 80.00 13.03

Price Performance

Historical Comparison
AUR
PTGX

About AUR Aurora Innovation Inc.

Aurora Innovation is a US autonomous driving provider for heavy trucks. The company produces and sells its Aurora Driver system, which includes hardware installed in a vehicle, software to autonomously drive it, and data management to maintain and improve the software. Aurora targets long-haul routes. The company currently offers its trucking-as-a-service model, where it owns and operates the trucks and makes deliveries for customers. The company plans to start selling its driver-as-a-service model next year, where fleet owners will own the trucks and Aurora's software will operate them.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: